Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like 9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To December 21, 2017 Bio-Tissue Announces Strategic Agreement With To Promote Its Regenerative Healing Technology In Canada October 3, 2017 Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million February 28, 2018
Bio-Tissue Announces Strategic Agreement With To Promote Its Regenerative Healing Technology In Canada October 3, 2017